A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,747,756 shares of PFE stock, worth $43.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,747,756
Previous 1,776,605 1.62%
Holding current value
$43.6 Million
Previous $49.7 Million 1.75%
% of portfolio
0.17%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$27.7 - $31.39 $799,117 - $905,570
-28,849 Reduced 1.62%
1,747,756 $50.6 Million
Q2 2024

Jul 26, 2024

BUY
$25.26 - $29.6 $1.91 Million - $2.23 Million
75,444 Added 4.43%
1,776,605 $49.7 Million
Q1 2024

Apr 24, 2024

BUY
$25.89 - $29.73 $2.89 Million - $3.32 Million
111,509 Added 7.01%
1,701,161 $47.2 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $3.57 Million - $4.63 Million
136,467 Added 9.39%
1,589,652 $45.8 Million
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $3.01 Million - $3.52 Million
-93,885 Reduced 6.07%
1,453,185 $48.2 Million
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $8.13 Million - $9.41 Million
225,184 Added 17.04%
1,547,070 $56.7 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $1.69 Million - $2.2 Million
-42,836 Reduced 3.14%
1,321,886 $53.9 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $90,054 - $117,556
-2,157 Reduced 0.16%
1,364,722 $69.9 Million
Q3 2022

Oct 17, 2022

SELL
$43.76 - $53.42 $849,119 - $1.04 Million
-19,404 Reduced 1.4%
1,366,879 $59.8 Million
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $333,247 - $395,127
7,162 Added 0.52%
1,386,283 $72.7 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $7.37 Million - $9.13 Million
-161,010 Reduced 10.45%
1,379,121 $71.4 Million
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $3.18 Million - $4.71 Million
76,914 Added 5.26%
1,540,131 $90.9 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $4.97 Million - $6.39 Million
-126,671 Reduced 7.97%
1,463,217 $62.9 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $3.78 Million - $4.28 Million
105,200 Added 7.09%
1,589,888 $62.3 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $124,616 - $140,542
-3,721 Reduced 0.25%
1,484,688 $53.8 Million
Q4 2020

Feb 04, 2021

BUY
$33.47 - $42.56 $1.28 Million - $1.63 Million
38,186 Added 2.63%
1,488,409 $54.8 Million
Q3 2020

Oct 29, 2020

BUY
$31.75 - $37.25 $3.91 Million - $4.59 Million
123,273 Added 9.29%
1,450,223 $50.5 Million
Q2 2020

Jul 27, 2020

BUY
$30.12 - $36.54 $560,292 - $679,717
18,602 Added 1.42%
1,326,950 $41.2 Million
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $6.33 Million - $9.04 Million
234,179 Added 21.8%
1,308,348 $40.5 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $2.17 Million - $2.47 Million
66,003 Added 6.55%
1,074,169 $39.9 Million
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $601,194 - $779,573
18,504 Added 1.87%
1,008,166 $34.4 Million
Q3 2019

Oct 28, 2019

SELL
$32.49 - $42.13 $188,377 - $244,269
-5,798 Reduced 0.58%
989,662 $33.7 Million
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $2.26 Million - $2.53 Million
61,005 Added 6.53%
995,460 $0
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $3.37 Million - $3.7 Million
-89,834 Reduced 8.77%
934,455 $0
Q4 2018

Feb 05, 2019

BUY
$38.47 - $43.86 $3.48 Million - $3.97 Million
90,438 Added 9.68%
1,024,289 $42.4 Million
Q3 2018

Nov 02, 2018

BUY
$34.47 - $41.81 $479,477 - $581,577
13,910 Added 1.51%
933,851 $0
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $807,317 - $860,681
-24,479 Reduced 2.59%
919,941 $0
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $3.75 Million - $4.35 Million
117,617 Added 14.23%
944,420 $0
Q4 2017

Feb 22, 2018

BUY
$33.26 - $35.29 $361,469 - $383,531
10,868 Added 1.33%
826,803 $0
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $391,654 - $431,451
12,634 Added 1.57%
815,935 $29.1 Million
Q2 2017

Aug 08, 2017

BUY
N/A
803,301
803,301 $27 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.